Literature DB >> 25203118

Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.

Robyn T Domsic1.   

Abstract

PURPOSE OF REVIEW: To discuss recent advances in serologic testing for systemic sclerosis (SSc)-associated antibodies with respect to the diagnosis and prognosis of the disease. RECENT
FINDINGS: The importance of SSc antibodies for diagnosis has become increasingly recognized, as evidenced by incorporation into the 2013 American College of Rheumatology/the European League Against Rheumatism clinical classification criteria for SSc. Two new SSc-associated antibodies and their clinical associations have been described. Multiple cohort studies have reported variable antibody frequency distribution based on geography, but the clinical associations remain much the same. New associations include anti-RNA polymerase III antibodies with gastric antral vascular ectasia, and a temporal association between SSc onset and RNA polymerase III antibodies.
SUMMARY: The role and associations of SSc-associated antibodies for diagnosis and internal organ involvement are becoming increasingly accepted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25203118      PMCID: PMC4299717          DOI: 10.1097/BOR.0000000000000113

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  23 in total

1.  Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.

Authors:  Tatiana S Rodriguez-Reyna; Andrea Hinojosa-Azaola; Cynthia Martinez-Reyes; Carlos A Nuñez-Alvarez; Rocío Torrico-Lavayen; José Luis García-Hernández; Javier Cabiedes-Contreras
Journal:  Autoimmunity       Date:  2011-08-30       Impact factor: 2.815

2.  Anti-PM-Scl antibody in patients with systemic sclerosis.

Authors:  Robert W Koschik; Noreen Fertig; Mary R Lucas; Robyn T Domsic; Thomas A Medsger
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

3.  Clinical and laboratory features dependent on age at onset in Japanese systemic sclerosis.

Authors:  Minoru Hasegawa; Yuri Hatta; Takashi Matsushita; Yasuhito Hamaguchi; Manabu Fujimoto; Kazuhiko Takehara
Journal:  Mod Rheumatol       Date:  2012-09-19       Impact factor: 3.023

4.  Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.

Authors:  Paolo Airo'; Angela Ceribelli; Ilaria Cavazzana; Mara Taraborelli; Stefania Zingarelli; Franco Franceschini
Journal:  J Rheumatol       Date:  2011-04-01       Impact factor: 4.666

5.  Clinical features of 405 Japanese patients with systemic sclerosis.

Authors:  Atsushi Hashimoto; Hirahito Endo; Hirobumi Kondo; Shunsei Hirohata
Journal:  Mod Rheumatol       Date:  2011-08-28       Impact factor: 3.023

6.  2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Ann Rheum Dis       Date:  2013-11       Impact factor: 19.103

7.  The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.

Authors:  Marie Vanthuyne; Vanessa Smith; Ellen De Langhe; Jens Van Praet; Seher Arat; Geneviève Depresseux; Rene Westhovens; Daniel Blockmans; Valérie Badot; Elie Cogan; Filip De Keyser; Frédéric A Houssiau
Journal:  J Rheumatol       Date:  2012-09-15       Impact factor: 4.666

8.  Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.

Authors:  Florian M P Meier; Klaus W Frommer; Robert Dinser; Ulrich A Walker; Laszlo Czirjak; Christopher P Denton; Yannick Allanore; Oliver Distler; Gabriela Riemekasten; Gabriele Valentini; Ulf Müller-Ladner
Journal:  Ann Rheum Dis       Date:  2012-05-21       Impact factor: 19.103

9.  Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.

Authors:  Mandana Nikpour; Pravin Hissaria; Jillian Byron; Joanne Sahhar; Maree Micallef; William Paspaliaris; Janet Roddy; Peter Nash; Alan Sturgess; Susanna Proudman; Wendy Stevens
Journal:  Arthritis Res Ther       Date:  2011-12-22       Impact factor: 5.156

10.  Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.

Authors:  Rudolf Mierau; Pia Moinzadeh; Gabriela Riemekasten; Inga Melchers; Michael Meurer; Frank Reichenberger; Michael Buslau; Margitta Worm; Norbert Blank; Rüdiger Hein; Ulf Müller-Ladner; Annegret Kuhn; Cord Sunderkötter; Aaron Juche; Christiane Pfeiffer; Christoph Fiehn; Michael Sticherling; Percy Lehmann; Rudolf Stadler; Eckhard Schulze-Lohoff; Cornelia Seitz; Ivan Foeldvari; Thomas Krieg; Ekkehard Genth; Nicolas Hunzelmann
Journal:  Arthritis Res Ther       Date:  2011-10-21       Impact factor: 5.156

View more
  22 in total

1.  Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis.

Authors:  Giuseppina Stifano; Thierry Sornasse; Lisa M Rice; Leo Na; Haiyin Chen-Harris; Dinesh Khanna; Angelika Jahreis; Yuqing Zhang; Jeff Siegel; Robert Lafyatis
Journal:  Arthritis Rheumatol       Date:  2018-06       Impact factor: 10.995

2.  Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease?

Authors:  Ramya Janardana; Aswin M Nair; Ajit K Surin; John Anthony Jude Prakash; Mahasampath Gowri; Debashish Danda
Journal:  Clin Rheumatol       Date:  2019-07-15       Impact factor: 2.980

3.  Enrichment of Scleroderma Vascular Disease-Associated Autoantigens in Endothelial Lineage Cells.

Authors:  Zsuzsanna H McMahan; Tricia R Cottrell; Fredrick M Wigley; Brendan Antiochos; Elias T Zambidis; Tea Soon Park; Marc K Halushka; Laura Gutierrez-Alamillo; Raffaello Cimbro; Antony Rosen; Livia Casciola-Rosen
Journal:  Arthritis Rheumatol       Date:  2016-10       Impact factor: 10.995

Review 4.  Clinical Trial Design Issues in Systemic Sclerosis: an Update.

Authors:  Jessica K Gordon; Robyn T Domsic
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 5.  Assessment of skin involvement in systemic sclerosis.

Authors:  Gábor Kumánovics; Márta Péntek; Sangmee Bae; Daniela Opris; Dinesh Khanna; Daniel E Furst; László Czirják
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

6.  Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis.

Authors:  Georgios Efthymiou; Christos Liaskos; Theodora Simopoulou; Emmanouela Marou; Eleni Patrikiou; Thomas Scheper; Wolfgang Meyer; Dimitrios Daoussis; Lazaros I Sakkas; Dimitrios P Bogdanos
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

7.  Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.

Authors:  Murray Baron; Janet Pope; David Robinson; Niall Jones; Nader Khalidi; Peter Docherty; Elzbieta Kaminska; Ariel Masetto; Evelyn Sutton; Jean-Pierre Mathieu; Sophie Ligier; Tamara Grodzicky; Sharon LeClercq; Carter Thorne; Geneviève Gyger; Douglas Smith; Paul R Fortin; Maggie Larché; Maysan Abu-Hakima; Tatiana S Rodriguez-Reyna; Antonio R Cabral-Castaneda; Marvin J Fritzler; Mianbo Wang; Marie Hudson
Journal:  Rheumatology (Oxford)       Date:  2016-09-04       Impact factor: 7.580

8.  Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.

Authors:  Emmanouela Marou; Christos Liaskos; Theodora Simopoulou; Georgios Efthymiou; Efthymios Dardiotis; Christina Katsiari; Thomas Scheper; Wolfgang Meyer; Georgios Hadjigeorgiou; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  Clin Rheumatol       Date:  2017-01-26       Impact factor: 2.980

Review 9.  Biomarkers in systemic sclerosis.

Authors:  Brian Skaug; Shervin Assassi
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

Review 10.  [Treatment of systemic sclerosis-associated interstitial lung disease].

Authors:  A Prasse; F Bonella; U Müller-Ladner; T Witte; N Hunzelmann; J Distler
Journal:  Z Rheumatol       Date:  2020-04       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.